August 17, 2025Journal of Current Hematology & Oncology Research

Evaluation of treatment regimens and prognostic factors in primary central nervous system lymphomas

View Full Paper

Ask AI

Bookmark

Authors

NANadiye Akdeniz SESenar Ebinç İBİbrahim Barışta

Discussion

Member takes

Overview

Retrospective analysis reveals consolidation therapy improves overall survival in primary central nervous system lymphoma patients, indicating significant prognostic factors.

Key Points

Consolidation therapy improves overall survival, reducing mortality risk by 67% compared to no therapy.
In this cohort of 84 patients, median overall survival was 18 months, and progression-free survival was 16.8 months.
Retrospective analysis assessed treatment effectiveness and prognostic factors in primary central nervous system lymphoma patients.
High-risk classification in the MSKCC model doubled mortality risk, emphasizing the importance of risk assessment.],
simple_explanation
Consolidation therapy can significantly improve outcomes for patients with primary central nervous system lymphoma (PCNSL). It was found to lower the risk of dying by about 67% compared to those who didn't receive it. In this analysis of nearly 85 patients, most received high-dose methotrexate, which helped achieve a good response rate. This shows that recognizing patient risks is crucial for planning effective treatments. 🧠
} trufiger }.
} } }{
}}} } } trufiger }.
} } }{
}}} } }, trufiger }.
} }] } } } } }},
{}, ٽ
}
} } } } },],'})
{
{
{
{
{ ft{
,
,
.dialog over 9
,
,
} ,
} } ,
,\nein
} ,
} ,
,
). } . }, } ,
, .
.
,
, } . } }
. },
} ) } . . } .
}
} } } ,
}
,
} } } } } } , } } } .
. } ,
} ,
. } },
,
. ,,
} . . . . } } } } } , trufiger }.
,
} . . } , }
} ,
, .
.
,
. }
. } ,
,
, , , , }} .}
}
. . } }},{}}]}
,}) diceDistinguish emulation XRC . `{}}. , . . '} , '.' ' , non = - ,
,
. ,} . ., {({}} + ({., -,} ). }}} . ,}} .
, ., . }
,
,
.
)

Cite This Study

Akdeniz et al. (2025) studied this question.

synapsesocial.com/papers/68c2368eb210217d64774bc0 https://doi.org/10.51271/jchor-0062

View Full Paper

Ask AI

Bookmark

August 17, 2025Journal of Current Hematology & Oncology Research

Evaluation of treatment regimens and prognostic factors in primary central nervous system lymphomas

View Full Paper

Ask AI

Bookmark

Authors

NANadiye Akdeniz SESenar Ebinç İBİbrahim Barışta

Discussion

Member takes

Overview

Retrospective analysis reveals consolidation therapy improves overall survival in primary central nervous system lymphoma patients, indicating significant prognostic factors.

Key Points

Consolidation therapy improves overall survival, reducing mortality risk by 67% compared to no therapy.
In this cohort of 84 patients, median overall survival was 18 months, and progression-free survival was 16.8 months.
Retrospective analysis assessed treatment effectiveness and prognostic factors in primary central nervous system lymphoma patients.
High-risk classification in the MSKCC model doubled mortality risk, emphasizing the importance of risk assessment.],
simple_explanation
Consolidation therapy can significantly improve outcomes for patients with primary central nervous system lymphoma (PCNSL). It was found to lower the risk of dying by about 67% compared to those who didn't receive it. In this analysis of nearly 85 patients, most received high-dose methotrexate, which helped achieve a good response rate. This shows that recognizing patient risks is crucial for planning effective treatments. 🧠
} trufiger }.
} } }{
}}} } } trufiger }.
} } }{
}}} } }, trufiger }.
} }] } } } } }},
{}, ٽ
}
} } } } },],'})
{
{
{
{
{ ft{
,
,
.dialog over 9
,
,
} ,
} } ,
,\nein
} ,
} ,
,
). } . }, } ,
, .
.
,
, } . } }
. },
} ) } . . } .
}
} } } ,
}
,
} } } } } } , } } } .
. } ,
} ,
. } },
,
. ,,
} . . . . } } } } } , trufiger }.
,
} . . } , }
} ,
, .
.
,
. }
. } ,
,
, , , , }} .}
}
. . } }},{}}]}
,}) diceDistinguish emulation XRC . `{}}. , . . '} , '.' ' , non = - ,
,
. ,} . ., {({}} + ({., -,} ). }}} . ,}} .
, ., . }
,
,
.
)

Cite This Study

Akdeniz et al. (2025) studied this question.

synapsesocial.com/papers/68c2368eb210217d64774bc0 https://doi.org/10.51271/jchor-0062

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark